Effect of contraceptive pill on the selenium and zinc status of healthy subjects

被引:19
作者
Fallah, Soudabeh [1 ]
Sani, Fatemeh Valinejad [1 ]
Firoozrai, Mohsen [1 ]
机构
[1] Iran Univ Med Sci, Dept Biochem, Fac Med, Tehran, Iran
关键词
Contraceptive pill; Trace element; Zinc; Selenium; ORAL-CONTRACEPTIVES; REPLACEMENT THERAPY; SERUM COPPER; FOLLOW-UP; ERYTHROCYTES; DISEASE; TISSUE; PLASMA; BRAIN; CYCLE;
D O I
10.1016/j.contraception.2009.01.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The study was conducted to ascertain the influence of oral contraceptive pill (OCP) uptake on serum zinc and selenium in contraceptive pill users. Study Design: The concentration of zinc and selenium was determined by atomic absorption spectrophotometer in 50 healthy women with normal menstrual cycles as a control group and 50 women taking low-dose OCP. Results: The control reference values were 81.61 +/- 9.44 and 70.35 +/- 25.57 mcg/dL, which were obtained for zinc and selenium, respectively. Use of OCP resulted in a significant decrease in serum zinc levels (p <=.009, t=-3.666) and alteration of selenium levels but not significantly (p=.08, t=0.935). The duration of use beyond 3 months had no effect on the magnitude of the decrease in serum zinc levels. Conclusions: These findings may be important because selenium is currently believed to offer protective benefits against carcinogenesis. It has been thought that the decrease in serum zinc could be reflected in a reduction of tissue zinc status due to changes in zinc absorption, excretion or tissue turnover. If these changes occur, the dietary zinc requirement would be greater in women using OCP. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 23 条
[1]  
BRENNEISEN P, 2005, MOL ASPECTS MED, V58, P155
[2]   The metallobiology of Alzheimer's disease [J].
Bush, AI .
TRENDS IN NEUROSCIENCES, 2003, 26 (04) :207-214
[3]  
CAGN SZ, 1979, TOXICOL APPL PHARM, V51, P107
[4]  
FRUNCKES CG, 1976, CONTRACEPTION, V14, P291
[5]   Determinants of serum copper, zinc and selenium in healthy subjects [J].
Ghayour-Mobarhan, M ;
Taylor, A ;
New, SA ;
Lamb, DJ ;
Ferns, GAA .
ANNALS OF CLINICAL BIOCHEMISTRY, 2005, 42 :364-375
[6]   SERUM ZINC LEVELS IN NORMAL AND ANOVULATORY CYCLE AND UNDER ORAL CONTRACEPTIVE THERAPY [J].
HAHN, N ;
FUCHS, C .
ARCHIV FUR GYNAKOLOGIE, 1974, 217 (03) :309-314
[7]   The effect of estrogen replacement therapy on zinc in serum and urine [J].
Herzberg, M ;
Lusky, A ;
Blonder, J ;
Frenkel, Y .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (06) :1035-1040
[8]  
HIDIROGLOU M, 1982, INT J VITAM NUTR RES, V52, P75
[9]   ZINC AND COPPER CONCENTRATIONS IN LEUKOCYTES AND ERYTHROCYTES IN HEALTHY-ADULTS AND THE EFFECT OF ORAL-CONTRACEPTIVES [J].
HINKS, LJ ;
CLAYTON, BE ;
LLOYD, RS .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (09) :1016-1021
[10]   ZINC AND DI-IODOHYDROXYQUINOLINE THERAPY IN ACRODERMATITIS-ENTEROPATHICA [J].
JACKSON, MJ .
JOURNAL OF CLINICAL PATHOLOGY, 1977, 30 (03) :284-287